He acknowledged challenges, including cumbersome DEA requirements and the fact that the only federal source of research marijuana, in Mississippi, grows low-quality product and authorizes few researchers to use it, leading researchers to sue for better access.

“These are addressable challenges. Congress can take specific action to enable easier access to cannabis that’s appropriate for medical research,” Gottlieb said. “Ultimately, we need to move past the social stigma around cannabis and address these complex public health and regulatory issues objectively.”

Former FDA commissioner says feds need to regulate marijuana – POLITICO

hmmm